A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding

- Wojtalewicz, Nathalie, Sadeqzadeh, Elham, Thorne, Rick F., Schwarte-Waldhoff, Irmgard, Weiß, Jakob V., Tehrani, Mahnaz Moradian, Klein-Scory, Susanne, Hahn, Stephan, Schmiegel, Wolff, Warnken, Uwe, Schnölzer, Martina, de Bock, Charles E.

Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein products

- Sadeqzadeh, Elham, de Bock, Charles E., Boyd, Andrew W., Burns, Gordon F., Thorne, Rick F., Zhang, Xu Dong, Shipman, Kristy L., Scott, Naomi M., Song, Chaojun, Yeadon, Trina, Oliveira, Camila S., Jin, Boquan, Hersey, Peter

Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44

- Thorne, Rick F., Wang, Yan, Zhang, Yan, Jing, Xueli, Zhang, Xu Dong, de Bock, Charles E., Oliveira, Camila S.

FAT1 cadherin acts upstream of Hippo signalling through TAZ to regulate neuronal differentiation

- Ahmed, Abdulrzag F., de Bock, Charles E., Lincz, Lisa F., Pundavela, Jay, Zouikr, Ihssane, Sontag, Estelle, Hondermarck, Hubert, Thorne, Rick F.

FAT1 cadherin controls neuritogenesis during NTera2 cell differentiation

- Ahmed, Abdulrzag F., de Bock, Charles E., Sontag, Estelle, Hondermarck, Hubert, Lincz, Lisa F., Thorne, Rick F.

FAT1 cadherin is multiply phosphorylated on its ectodomain but phosphorylation is not catalysed by the four-jointed homologue

- Sadeqzadeh, Elham, de Bock, Charles E., O'Donnell, Maureen R., Timofeeva, Anna, Burns, Gordon F., Thorne, Rick F.

Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia

- Ardjmand, Alireza, de Bock, Charles E., Shahrokhi, Somayeh, Lincz, Lisa F., Boyd, Andrew W., Burns, Gordon F., Thorne, Rick F.

Furin processing dictates ectodomain shedding of human FAT1 cadherin

- Sadeqzadeh, Elham, de Bock, Charles E., Wojtalewicz, Natalie, Holt, Janet E., Smith, Nathan D., Dun, Matthew D., Schwarte-Waldhoff, Irmgard, Thorne, Rick F.

Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma

- Oliveira, Camila S., de Bock, Charles E., Molloy, Timothy J., Sadeqzadeh, Elham, Geng, Xin Yan, Hersey, Peter, Zhang, Xu Dong, Thorne, Rick F.

PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma

- Ye, Yan, Jin, Lei, Tay, Kwang Hong, Tseng, Hsin-Yi, Guo, Su Tang, de Bock, Charles E., Jiang, Chen Chen, Wang, Chun Yang, Wu, Mian, Zhang, Lie Jie, Hersey, Peter, Scolyer, Richard A., Wilmott, James S., Zhang, Xu Dong, Hu, Wang Lai, Yosufi, Benafsha, Thorne, Rick F., Liu, Tao, Rizos, Helen, Yan, Xu Guang, Dong, Li

Protein interaction screening identifies SH3RF1 as a new regulator of FAT1 protein levels

- de Bock, Charles E., Hughes, Michael R., Snyder, Kimberly, Alley, Steven, Sadeqzadeh, Elham, Dun, Matt D., McNagny, Kelly M., Molloy, Timothy J., Hondermarck, Hubert, Thorne, Rick F.

Sleeping giants: emerging roles for the Fat cadherins in health and disease

- Sadeqzadeh, Elham, de Bock, Charles E., Thorne, Rick F.

T-cell acute lymphoblastic leukemia express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development

- de Bock, Charles E., Down, Michelle, Baidya, Kinsha, Sweron, Bram, Boyd, Andrew W., Fiers, Mark, Burns, Gordon F., Molloy, Timothy J., Lock, Richard B., Soulier, Jean, Taghon, Tom, Van Vlierberghe, Pieter, Cools, Jan, Holst, Jeff, Thorne, Rick F.

The Promise of Single-cell Technology in Providing New Insights into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia

- Pearson, Holly C. L., Hunt, Kooper V., Trahair, Toby N., Lock, Richard B., Lee, Heather J., de Bock, Charles E.